Anderson Bauer, MD
Radiation Oncology · Marshfield, WINPI 1043422207
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,036 of the $1,641 with a category attached, or 63.1%. 28 manufacturers reported payments, led by GT Medical Technologies, Inc at 30.5% of the total. Reporting peaked in 2019 at $744 and has fallen 95.6% since, to $33 in 2025.
Across 53 payments — averaging $30.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GT Medical Technologies, Inc$500
- Astellas Pharma US Inc$118
- Lilly USA, LLC$117
- Bayer$103
- Varian Medical Systems, Inc.$79
- E.r. Squibb & Sons, L.L.C.$60
- plus $664 from 22 others
What the payments were for
- Consulting fees$50030%
- Food & beverage$1,03663%
- Education$1056%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GT Medical Technologies, Inc | 1 | $500 |
| Astellas Pharma US Inc | 3 | $118 |
| Lilly USA, LLC | 2 | $117 |
| Bayer | 5 | $103 |
| Varian Medical Systems, Inc. | 1 | $79 |
| E.r. Squibb & Sons, L.L.C. | 4 | $60 |
| Seagen Inc. | 4 | $59 |
| AbbVie | 3 | $50 |
| AstraZeneca | 2 | $50 |
| Regeneron Healthcare Solutions, Inc. | 2 | $50 |
| Bristol Myers Squibb | 2 | $47 |
| Novartis | 3 | $45 |
| Johnson & Johnson | 2 | $44 |
| Amgen | 2 | $39 |
| Pfizer | 2 | $35 |
| Daiichi Sankyo Inc. | 2 | $34 |
| Sanofi | 2 | $29 |
| Tactile Systems Technology Inc | 1 | $23 |
| Rigel Pharmaceuticals, Inc. | 1 | $23 |
| Boston Scientific | 1 | $21 |
| Sun Pharmaceutical Industries Inc. | 1 | $19 |
| Merck | 1 | $18 |
| Mylan Institutional Inc. | 1 | $18 |
| Qfix | 1 | $14 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $13 |
| Carbofix Orthopedics Inc | 1 | $12 |
| Ipsen Biopharmaceuticals, Inc | 1 | $12 |
| Clovis Oncology, Inc. | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,641 in reported general payments places this provider in the 85th percentile of 131 radiation oncology providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 17 | $242 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Marshfield
- Timothy KruserMadison$235K
- Stephen RosenbergMadison$18K
- Matthew WitekMadison$11K
- Anna BrownWausau$9K
- Joseph BoviMilwaukee$6K
- William HallMilwaukee$5K
- Jessica SchusterJohnson Creek$5K
- Lindsay PuckettMilwaukee$4K
- Douglas CalvinAppleton$4K
- Michael ChristensenFranklin$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.